Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Journal of Medicinal Chemistry|December 4, 2008
Improving tumor uptake and excretion kinetics of 99mTc-labeled cyclic arginine-glycine-aspartic (RGD) dimers with triglycine linkersJiyun Shi, Lijun Wang, Young-Seung Kim, et al.
Theranostics|August 19, 2011
Evaluation of In-Labeled Cyclic RGD Peptides: Effects of Peptide and Linker Multiplicity on Their Tumor Uptake, Excretion Kinetics and Metabolic StabilityJiyun Shi, Yang Zhou, Sudipta Chakraborty, et al.
Cancer Medicine|January 10, 2014
Gene expression profiling upon (212) Pb-TCMC-trastuzumab treatment in the LS-174T i.p. xenograft modelKwon J Yong, Diane E Milenic, Kwamena E Baidoo, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 2, 2009
99mTcO(MAG2-3G3-dimer): a new integrin alpha(v)beta(3)-targeted SPECT radiotracer with high tumor uptake and favorable pharmacokineticsJiyun Shi, Lijun Wang, Young-Seung Kim, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2012
Synthesis and characterization of αvβ₃-targeting peptidomimetic chelate conjugates for PET and SPECT imagingYoung-Seung Kim, Kido Nwe, Diane E Milenic, et al.
Journal of Medicinal Chemistry|April 19, 2008
Effects of targeting moiety, linker, bifunctional chelator, and molecular charge on biological properties of 64Cu-labeled triphenylphosphonium cationsYoung-Seung Kim, Chang-Tong Yang, Jianjun Wang, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 7, 2015
First-In-Human Study Demonstrating Tumor-Angiogenesis by PET/CT Imaging with (68)Ga-NODAGA-THERANOST, a High-Affinity Peptidomimetic for αvβ3 Integrin Receptor TargetingRichard P Baum, Harshad R Kulkarni, Dirk Müller, et al.
Bioconjugate Chemistry|March 8, 2007
Evaluation of a (99m)Tc-labeled cyclic RGD tetramer for noninvasive imaging integrin alpha(v)beta3-positive breast cancerShuang Liu, Wen-Yuan Hsieh, Young Jiang, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 20, 2018
Exploration of a F(ab')2 Fragment as the Targeting Agent of α-Radiation Therapy: A Comparison of the Therapeutic Benefit of Intraperitoneal and Intravenous Administered RadioimmunotherapyDiane E Milenic, Young-Seung Kim, Kwamena E Baidoo, et al.
Molecular Pharmaceutics|December 11, 2008
Improving tumor-targeting capability and pharmacokinetics of (99m)Tc-labeled cyclic RGD dimers with PEG(4) linkersLijun Wang, Jiyun Shi, Young-Seung Kim, et al.
Pageof 5